Subscribe
hynci-istockphoto-com-dollars-cash-
hynci / iStockphoto.com
13 August 2018Americas

PhRMA members invested $71.4bn in R&D in 2017

Members of the Pharmaceutical Research and Manufacturers of America (PhRMA) last year obtained the highest-ever level of investment for the industry group, recording $71.4 billion of funding in research and development (R&D).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
PhRMA shames Brazil and Thailand over patent backlogs
6 November 2018   Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.
Americas
PhRMA cuts membership, increases R&D requirements
11 May 2017   The Pharmaceutical Research and Manufacturers of America has cut 22 members based on a new set of membership criteria it introduced on Tuesday, May 9.


Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

Editor's picks

Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Americas
PhRMA shames Brazil and Thailand over patent backlogs
6 November 2018   Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.
Americas
PhRMA cuts membership, increases R&D requirements
11 May 2017   The Pharmaceutical Research and Manufacturers of America has cut 22 members based on a new set of membership criteria it introduced on Tuesday, May 9.

More on this story

Americas
PhRMA shames Brazil and Thailand over patent backlogs
6 November 2018   Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.
Americas
PhRMA cuts membership, increases R&D requirements
11 May 2017   The Pharmaceutical Research and Manufacturers of America has cut 22 members based on a new set of membership criteria it introduced on Tuesday, May 9.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?